Midwifery Pharmacology-32
Midwifery Pharmacology-32
Midwifery Pharmacology-32
The student is expected to document all meds the client is currently receiving.
MEDICATION NAME DOSE, ROUTE, EFFECTS PREGANCY
GENERIC/TRADE INDICATION/ ACTION TIMES FOOD/DRUG SIDE EFFECTS FETUS AND/OR NURSING CONSIDERATIONS
CLASSIFICATION DOSGE/RANGE INTERACTIONS NEONATE
(PHARM) AND (include therapeutic
PREGNANCY dose calculation)
CATEGORY
Recombinant hepatiis B is used as a IM (Neonates) Unknown The only common side Recommended for Delay administration during active
Hepatitis B prophylactic treatment against all 0.5ml (10mcg) effect is soreness at the Newborn/Infants infection, the vaccine will not prevent
subtypes of the hepatitis B virus. It into the injection site. birth to 2 months for infection during its incubation period.
Vaccine proides passive immunization for anterolateral Occasionally, there is first dose of hepatitis
newborns of HbsAg-negative and thigh within 12 erythema, swelling, B. Second dose The vaccine should be used as
. positive HbsAg-positive mothers. hours of birth for warmth, and indurations should be 1 month supplied, do not dilute, shake well. Do
Hepatitis B can be transmitted across infants born to at injection site, irritability after first dose, Third not inject intravenously or
Classification the placenta, but most newborns are of HbsAg- or low-grade fever. dose should be given interdermally.
Vaccine infected during birth. positive 4 months after first
mothers. The 2nd dose or at least 2 Monitor for adverse reactions,
Preg. Cat. UK The vaccine is produced form bakers’ dose of vaccineis months after second temperature closely. Have
yeast and plasmid containing the given at 1 month dose. epinephrine available to treat possible
Olds’s Maternal and HbsAg gene. Hepatitis B (thimerosal of age and allergic reactions. Responsiveness to
Newborn Nursing free) vaccine contains more ha 95% followed by a the vaccine is age dependent.
Page 883-884 HbsAg protein and is an inactivated final dose at 6 Preterm infants weighing less than
(noninfective) product. Universal months of age. 1000g have lower serconversion
immunization is recommended. rates. Consider delaying the first dose
Infants with HbsAg-positive mothers until the infant is term post conceptual
should concurrently receive 0.5 ml of age or use a 4-dose schedule.
Hepatitis B immunoglobulin (HBIG)
prophylaxis at separate injection sites
PHARM